MX340424B - Compuestos novedosos de mimeticos de cambio inverso; metodo para fabricarlos y su uso. - Google Patents

Compuestos novedosos de mimeticos de cambio inverso; metodo para fabricarlos y su uso.

Info

Publication number
MX340424B
MX340424B MX2011010765A MX2011010765A MX340424B MX 340424 B MX340424 B MX 340424B MX 2011010765 A MX2011010765 A MX 2011010765A MX 2011010765 A MX2011010765 A MX 2011010765A MX 340424 B MX340424 B MX 340424B
Authority
MX
Mexico
Prior art keywords
manufacturing
turn mimetics
reverse
same
novel compounds
Prior art date
Application number
MX2011010765A
Other languages
English (en)
Other versions
MX2011010765A (es
Inventor
Uk Chung Jae
Lee Yong-Sil
Jung Hee-Kyung
Jung Kyung-Yun
La Hyun-Ju
Wook Jeong Min-
Ma Sang-Ho
Original Assignee
Jw Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jw Pharmaceutical Corp filed Critical Jw Pharmaceutical Corp
Publication of MX2011010765A publication Critical patent/MX2011010765A/es
Publication of MX340424B publication Critical patent/MX340424B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65611—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. penicillins and analogs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Se describen miméticos novedosos de giro inverso, basados en el marco de pirazino-triazinona y su uso en el tratamiento de cánceres, en particular de leucemia mieloide aguda. También se provee un método para fabricar los miméticos de giro inverso, a escala masiva.
MX2011010765A 2009-04-15 2010-04-14 Compuestos novedosos de mimeticos de cambio inverso; metodo para fabricarlos y su uso. MX340424B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20090032937 2009-04-15
PCT/KR2010/002306 WO2010120112A2 (en) 2009-04-15 2010-04-14 Novel compounds of reverse-turn mimetics, method for manufacturing the same and use thereof

Publications (2)

Publication Number Publication Date
MX2011010765A MX2011010765A (es) 2012-02-08
MX340424B true MX340424B (es) 2016-07-08

Family

ID=42981437

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011010765A MX340424B (es) 2009-04-15 2010-04-14 Compuestos novedosos de mimeticos de cambio inverso; metodo para fabricarlos y su uso.

Country Status (14)

Country Link
US (1) US20100267672A1 (es)
EP (1) EP2419430A4 (es)
JP (1) JP5657642B2 (es)
KR (1) KR101692921B1 (es)
CN (1) CN102459271B (es)
AU (1) AU2010237633B2 (es)
BR (1) BRPI1014574A2 (es)
CA (1) CA2758904C (es)
IL (1) IL215732A (es)
MX (1) MX340424B (es)
RU (1) RU2515983C2 (es)
SG (1) SG175045A1 (es)
WO (1) WO2010120112A2 (es)
ZA (1) ZA201107357B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2011096440A1 (ja) 2010-02-03 2013-06-10 株式会社 ＰＲＩＳＭ ＢｉｏＬａｂ 天然変性タンパク質に結合する化合物およびそのスクリーニング方法
ES2552462T3 (es) * 2010-10-14 2015-11-30 Jw Pharmaceutical Corporation Nuevo compuesto de un mimético de giro inverso y un procedimiento de producción y uso del mismo
WO2012115286A1 (en) * 2011-02-25 2012-08-30 Prism Biolab Corporation Alpha helix mimetics and methods relating thereto
US9353119B2 (en) 2011-08-09 2016-05-31 Jw Pharmaceutical Corporation Composition for preventing and treating non-small cell lung cancer, containing pyrazino-triazine derivatives
ES2577863T3 (es) 2011-08-09 2016-07-19 Jw Pharmaceutical Corporation Composición para la prevención y el tratamiento del cáncer de pulmón de células no pequeñas, que contiene derivados de pirazino-triazina
KR20140053952A (ko) * 2011-08-26 2014-05-08 제이더블유중외제약 주식회사 피라지노-트리아진 유도체를 포함하는 조성물
SG11201601767YA (en) * 2013-09-11 2016-04-28 Prism Pharma Co Ltd Method of producing pyrazino[2,1-c][1,2,4]triazine compound
WO2015074064A2 (en) 2013-11-18 2015-05-21 Bair Kenneth W Tetrahydroquinoline compositions as bet bromodomain inhibitors
US9422281B2 (en) * 2013-11-18 2016-08-23 Forma Therapeutics, Inc. Benzopiperazine compositions as BET bromodomain inhibitors
US9174998B2 (en) * 2013-12-25 2015-11-03 Eisai R&D Management Co., Ltd. (6S,9aS)-N-benzyl-6-[(4-hydroxyphenyl)methyl]-4,7-dioxo-8-({6-[3-(piperazin-1-yl)azetidin-1-yl]pyridin-2-yl}methyl)-2-(prop-2-en-1-yl)-octahydro-1H-pyrazino[2,1-c][1,2,4]triazine-1-carboxamide compound
MX373231B (es) 2015-06-16 2020-05-08 Eisai R&D Man Co Ltd Agente anticancerigeno.
KR102559211B1 (ko) 2015-06-23 2023-07-25 에자이 알앤드디 매니지먼트 가부시키가이샤 (6S,9aS)-N-벤질-8-({6-[3-(4-에틸피페라진-1-일)아제티딘-1-일]피리딘-2-일}메틸)-6-(2-플루오로-4-하이드록시벤질)-4,7-디옥소-2-(프로프-2-엔-1-일)헥사하이드로-2H-피라지노[2,1-c][1,2,4]트리아진-1(6H)-카복사마이드의 결정
US12303505B2 (en) 2017-02-08 2025-05-20 Eisai R&D Management Co., Ltd. Tumor-treating pharmaceutical composition
BR112019023064A2 (pt) 2017-05-16 2020-06-09 Eisai R&D Man Co Ltd tratamento de carcinoma hepatocelular
TWI846350B (zh) 2017-09-15 2024-06-21 美商佛瑪治療公司 作為ＣＢＰ／ｐ３００抑制劑之四氫－咪唑並喹啉化合物
MX2023013508A (es) 2018-06-29 2023-12-13 Forma Therapeutics Inc Inhibicion de la proteina de union a creb (cbp).
US12351577B2 (en) 2019-03-15 2025-07-08 Forma Therapeutics, Inc. Inhibiting cyclic AMP-responsive element-binding protein (CREB)
KR20210153908A (ko) 2020-06-11 2021-12-20 제이더블유중외제약 주식회사 코로나바이러스감염증-19(covid-19) 치료용 조성물
KR20220000460A (ko) 2020-06-26 2022-01-04 제이더블유중외제약 주식회사 폐섬유화증 치료용 조성물
US11801243B2 (en) 2020-09-23 2023-10-31 Forma Therapeutics, Inc. Bromodomain inhibitors for androgen receptor-driven cancers
US11795168B2 (en) 2020-09-23 2023-10-24 Forma Therapeutics, Inc. Inhibiting cyclic amp-responsive element-binding protein (CREB) binding protein (CBP)

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US559184A (en) * 1896-04-28 Eli marshall
JPH06505486A (ja) * 1991-02-07 1994-06-23 モレキュメティクス，リミティド βターンおよびβバルジのコンフォメーション的に制限された模倣物およびそれらを含有するペプチド
US5475085A (en) * 1991-02-07 1995-12-12 Molecumetics, Ltd. Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same
EP0656907A1 (en) 1992-08-06 1995-06-14 Molecumetics, Ltd. Conformationally restricted mimetics of reverse turns and peptides containing the same
US5446128A (en) * 1993-06-18 1995-08-29 The Board Of Trustees Of The University Of Illinois Alpha-helix mimetics and methods relating thereto
US5693325A (en) * 1994-03-15 1997-12-02 Molecumetics, Ltd. Peptide vaccines and methods relating thereto
US6020331A (en) * 1995-03-24 2000-02-01 Molecumetics, Ltd. β-sheet mimetics and use thereof as protease inhibitors
US6245764B1 (en) * 1995-03-24 2001-06-12 Molecumetics Ltd. β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
US6184223B1 (en) * 1995-10-27 2001-02-06 Molecumetics Ltd. Reverse-turn mimetics and methods relating thereto
US5840833A (en) * 1995-10-27 1998-11-24 Molecumetics, Ltd Alpha-helix mimetics and methods relating thereto
US6013458A (en) * 1995-10-27 2000-01-11 Molecumetics, Ltd. Reverse-turn mimetics and methods relating thereto
US5929237A (en) * 1995-10-27 1999-07-27 Molecumetics Ltd. Reverse-turn mimetics and methods relating thereto
US6117896A (en) * 1997-02-10 2000-09-12 Molecumetics Ltd. Methods for regulating transcription factors
US6451972B1 (en) * 1998-11-16 2002-09-17 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors
US7192494B2 (en) * 1999-03-05 2007-03-20 Applied Materials, Inc. Method and apparatus for annealing copper films
US6294525B1 (en) * 1999-09-01 2001-09-25 Molecumetics Ltd. Reverse-turn mimetics and methods relating thereto
US6872825B2 (en) * 1999-12-21 2005-03-29 The Procter & Gamble Company Peptide β-turn mimetic compounds and processes for making them
DE10005631A1 (de) * 2000-02-09 2001-08-23 Max Planck Gesellschaft Arginin-Mimetika als Faktor X¶a¶-Inhibitoren
JP4387793B2 (ja) * 2001-10-12 2009-12-24 チョンウェ ファーマ コーポレーション 逆向ターンミメティックおよびそれに関連した方法
US7566711B2 (en) * 2001-10-12 2009-07-28 Choongwae Pharma Corporation Reverse-turn mimetics and method relating thereto
US7576084B2 (en) * 2001-10-12 2009-08-18 Choongwae Pharma Corporation Reverse-turn mimetics and method relating thereto
US7671054B1 (en) * 2001-10-12 2010-03-02 Choongwae Pharma Corporation Reverse-turn mimetics and method relating thereto
US20040072831A1 (en) * 2001-10-12 2004-04-15 Choongwae Pharma Corporation Reverse-turn mimetics and method relating thereto
US7232822B2 (en) * 2001-10-12 2007-06-19 Choongwae Pharma Corporation Reverse-turn mimetics and method relating thereto
US8080657B2 (en) * 2001-10-12 2011-12-20 Choongwae Pharma Corporation Compounds of reverse turn mimetics and the use thereof
US6762185B1 (en) * 2002-03-01 2004-07-13 Choongwae Pharma Corporation Compounds useful for treatment of cancer, compositions containing the same, and methods of their use
CN1871239A (zh) * 2003-08-28 2006-11-29 (株)中外制药 β－联蛋白/TCF激活转录的调节
US7563825B1 (en) * 2005-03-18 2009-07-21 Choongwae Pharma Corporation Modulation of beta-catenin coactivator interactions to effect stem cell growth or differentiation
WO2007056593A2 (en) * 2005-11-08 2007-05-18 Choongwae Pharma Corporation α-HELIX MIMETICS AND METHOD RELATING TO THE TREATMENT OF CANCER STEM CELLS
US20090215783A1 (en) * 2006-05-30 2009-08-27 Choongwae Pharma Corporation Composition for induction or inhibition of stem cell differentiation

Also Published As

Publication number Publication date
WO2010120112A3 (en) 2011-03-31
JP2012524061A (ja) 2012-10-11
EP2419430A4 (en) 2012-10-31
AU2010237633A1 (en) 2011-10-27
BRPI1014574A2 (pt) 2015-08-25
CN102459271A (zh) 2012-05-16
SG175045A1 (en) 2011-11-28
KR101692921B1 (ko) 2017-01-05
RU2011146146A (ru) 2013-05-20
RU2515983C2 (ru) 2014-05-20
US20100267672A1 (en) 2010-10-21
CN102459271B (zh) 2014-07-02
AU2010237633B2 (en) 2015-09-17
KR20120028877A (ko) 2012-03-23
IL215732A (en) 2014-08-31
ZA201107357B (en) 2012-07-25
WO2010120112A2 (en) 2010-10-21
EP2419430A2 (en) 2012-02-22
IL215732A0 (en) 2012-01-31
JP5657642B2 (ja) 2015-01-21
MX2011010765A (es) 2012-02-08
CA2758904C (en) 2017-04-04
CA2758904A1 (en) 2010-10-21

Similar Documents

Publication Publication Date Title
MX340424B (es) Compuestos novedosos de mimeticos de cambio inverso; metodo para fabricarlos y su uso.
EG25214A (en) Process for the production of ethylene oxide and ethylene glycol.
EP2499209B8 (en) Surface treatment composition, process for producing the same, and surface-treated article
EP1908749A4 (en) PROCESS FOR PREPARING ISOCYANATE, ISOCYANATE MADE ACCORDING TO IT AND USE OF ISOCYANATE
EP2239054A4 (en) CATALYST, MANUFACTURING METHOD AND USE THEREOF
MX2010002836A (es) Bortezomib y proceso para la produccion del mismo.
IL204555A0 (en) (carboxylalkylene-phenyl) phenyl-oxalamides, method for the production thereof, and use of same as a medicatment
EP2085493A4 (en) PROCESS FOR MANUFACTURING HIGH CONCENTRATION CEMENTYED STEEL
PL2222642T3 (pl) Sposób i związki do wytwarzania (+) opiatów
ZA200900321B (en) Beverage precursor and process for the manufacture thereof
EP2418301A4 (en) SURFACE TREATMENT AGENT, METHOD FOR PRODUCING PLATED STEEL PLATE WITH THE SURFACE TREATMENT AND PLATED STEEL PLATE
IN2012DN01968A (es)
EP2239055A4 (en) CATALYST, MANUFACTURING METHOD AND USE THEREOF
ZA201101340B (en) Production of silicon by reacting silicon oxide and silicon carbide,optionally in the presence of a second carbon source
EP2273969A4 (en) TOPICAL COMPOSITION FOR EXTERNAL USE AND METHOD OF MANUFACTURING THE SAME
EP2226407A4 (en) METHOD FOR MANUFACTURING METALLIC FILM, METALLIC FILM, AND USE OF METALLIC FILM
PL2225314T3 (pl) Samoprzywierające silikony, sposób ich wytwarzania, stosujące je kompleksy i zastosowanie
IL200000A (en) Process for Preparing 5- (1- Alkylthio) Alkylpyridines are Stored in Position 2 and Its Compounds
EP1914026A4 (en) TWO-PART BOX MANUFACTURING METHOD AND TWO-PART STATIZED BOX
EP1978286A4 (en) REDUCED FRICTION COEFFICIENT BODY, PRODUCTION APPARATUS THEREFOR, AND PROCESS FOR PRODUCING THE SAME
ZA201104635B (en) Process for preparing zanamivir and intermediates for use in the process
EP2085061A4 (en) METHOD OF MANUFACTURING ABSORBENT ARTICLE AND ABSORBENT ARTICLE
SG120243A1 (en) Hydrogen production process
ZA201001292B (en) Beverage precursor and process for the manufacture thereof
HU0600668D0 (en) Active carrier, process for producing thereof and the use of thereof

Legal Events

Date Code Title Description
FG Grant or registration